Buscar por Materia Cancer

Ir a una fecha de inicio:
Mostrando resultados 35 a 54 de 109 < Anterior   Siguiente >
Vista previaFecha de publicaciónFecha de CreaciónTítulo
Clinical significance of FAK expression in human neoplasia.pdf.jpg2008-Clinical significance of FAK expression in human neoplasia
EPH receptors in cancer.pdf.jpg2008-EPH receptors in cancer
Expression of K+ channels in normal and cancerous human breast.pdf.jpg2008-Expression of K+ channels in normal and cancerous human breast
Loss of a reporter gene for green fluorescent protein during tumor progression suggests the recruitment of host.pdf.jpg2008-Loss of a reporter gene for green fluorescent protein during tumor progression suggests the recruitment of host cells in rats with experimentally induced colon cancer
Tea polyphenols, their biological effects and potential molecular targets.pdf.jpg2008-Tea polyphenols, their biological effects and potential molecular targets
Tie2, a journey from normal angiogenesis to cancer and beyond.pdf.jpg2008-Tie2, a journey from normal angiogenesis to cancer and beyond
Int J cancer 2008.pdf.jpg15-nov-2008-Targeting the methionine cycle for melanoma therapy with 3-O-(3,4,5-trimethoxybenzoyl)-(-)-epicatechin
Melatonin modulates microfilament phenotypes in epithelial cells implications.pdf.jpg2009-Melatonin modulates microfilament phenotypes in epithelial cells, implications for adhesion and inhibition of cancer cell migration
Focal adhesion kinase and cancer.pdf.jpg2009-Focal adhesion kinase and cancer
The transcription factor Fos a Janustype regulator in health and disease.pdf.jpg2009-The transcription factor Fos, a Janus-type regulator in health and disease
Receptorbinding cancer antigen expressed on SiSo cells RCAS1 a novel biomarker.pdf.jpg2009-Receptor-binding cancer antigen expressed on SiSo cells (RCAS1), a novel biomarker in the diagnosis and prognosis of human neoplasia
Annexins as disease modifiers.pdf.jpg2010-Annexins as disease modifiers
MCM proteins as diagnostic and prognostic tumor markers in the clinical setting.pdf.jpg2010-MCM proteins as diagnostic and prognostic tumor markers in the clinical setting
Molecular Nutrition Food Res - 2010 - González‐Sarrías - Occurrence of urolithins  gut microbiota ellagic acid metabolites.pdf.jpgmar-2010-Occurrence of urolithins, gut microbiota ellagic acid metabolites and proliferation markers expression response in the human prostate gland upon consumption of walnuts and pomegranate juice
An immunohistochemical study of cyclooxygenase-2 expression in canine multicentric lymphoma.pdf.jpg2011-An immunohistochemical study of cyclooxygenase-2 expression in canine multicentric lymphoma
Heron-Milhavet-26-651-662-2011.pdf.jpg2011-Akt1 and Akt2: Differentiating the aktion
Romero-Camarero-27-157-170-2012.pdf.jpg2012-New models towards assessing anti-cancer therapeutics
Shah-27-567-579-2012.pdf.jpg2012-High mobility group A1 and cancer: Potential biomarker and therapeutic target
Zhu-27-257-261-2012.pdf.jpg2012-BAG3: a new therapeutic target of human cancers?
Park-27-197-207-2012.pdf.jpg2012-High MET copy number and MET overexpression: Poor outcome in non-small cell lung cancer patients